rs4049505
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000496.3(CRYBB2):c.449+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.691 in 1,613,564 control chromosomes in the GnomAD database, including 388,526 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 39477 hom., cov: 35)
Exomes 𝑓: 0.69 ( 349049 hom. )
Consequence
CRYBB2
NM_000496.3 intron
NM_000496.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.60
Publications
6 publications found
Genes affected
CRYBB2 (HGNC:2398): (crystallin beta B2) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B3. A chain-terminating mutation was found to cause type 2 cerulean cataracts. [provided by RefSeq, Jul 2008]
CRYBB2 Gene-Disease associations (from GenCC):
- cataract 3 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset posterior subcapsular cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset sutural cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- total early-onset cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 22-25229587-G-A is Benign according to our data. Variant chr22-25229587-G-A is described in ClinVar as [Benign]. Clinvar id is 256282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.936 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.716 AC: 108986AN: 152134Hom.: 39456 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
108986
AN:
152134
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.726 AC: 181914AN: 250512 AF XY: 0.724 show subpopulations
GnomAD2 exomes
AF:
AC:
181914
AN:
250512
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.688 AC: 1005378AN: 1461312Hom.: 349049 Cov.: 69 AF XY: 0.691 AC XY: 502014AN XY: 726946 show subpopulations
GnomAD4 exome
AF:
AC:
1005378
AN:
1461312
Hom.:
Cov.:
69
AF XY:
AC XY:
502014
AN XY:
726946
show subpopulations
African (AFR)
AF:
AC:
26335
AN:
33472
American (AMR)
AF:
AC:
34347
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
AC:
17737
AN:
26128
East Asian (EAS)
AF:
AC:
38154
AN:
39696
South Asian (SAS)
AF:
AC:
67537
AN:
86214
European-Finnish (FIN)
AF:
AC:
34673
AN:
53386
Middle Eastern (MID)
AF:
AC:
4390
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
739724
AN:
1111606
Other (OTH)
AF:
AC:
42481
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
19112
38224
57337
76449
95561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.716 AC: 109059AN: 152252Hom.: 39477 Cov.: 35 AF XY: 0.716 AC XY: 53306AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
109059
AN:
152252
Hom.:
Cov.:
35
AF XY:
AC XY:
53306
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
32513
AN:
41548
American (AMR)
AF:
AC:
10702
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
2329
AN:
3468
East Asian (EAS)
AF:
AC:
4964
AN:
5182
South Asian (SAS)
AF:
AC:
3875
AN:
4830
European-Finnish (FIN)
AF:
AC:
6838
AN:
10608
Middle Eastern (MID)
AF:
AC:
221
AN:
292
European-Non Finnish (NFE)
AF:
AC:
45439
AN:
67996
Other (OTH)
AF:
AC:
1540
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1645
3290
4935
6580
8225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2988
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cataract 3 multiple types Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.